Ligand Pharm
(LGND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,141 | -96,471 | -52,257 | -42,995 | -72,376 |
| Depreciation Amortization | 15,275 | 14,328 | 8,723 | 15,561 | 15,457 |
| Accounts receivable | -11,946 | -6,478 | 275 | -6,974 | -1,389 |
| Other Working Capital | 41,192 | 69,915 | 13,451 | -42 | 7,741 |
| Other Operating Activity | 6,374 | 19,019 | 2,918 | 14,544 | 5,352 |
| Operating Cash Flow | $5,754 | $313 | $-26,890 | $-19,906 | $-45,215 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,142 | -17,973 | 4,120 | -2,479 | 2,934 |
| PPE Investments | -3,604 | -2,783 | -3,161 | -1,974 | 8,591 |
| Purchase Sale Intangibles | N/A | -4,133 | -106,304 | N/A | N/A |
| Other Investing Activity | 9,073 | 6,521 | -125,078 | 281 | 986 |
| Investing Cash Flow | $19,611 | $-14,235 | $-124,119 | $-4,172 | $12,511 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,429 | 1,114 | 152,976 | 11,552 | 1,442 |
| Debt Repayment | -2,944 | -2,468 | -53,640 | -3,597 | -4,188 |
| Common Stock Issued | 6,619 | 49,451 | 70,755 | 28,576 | 14,194 |
| Common Stock Repurchased | N/A | -15,867 | N/A | N/A | N/A |
| Other Financing Activity | -189 | -101 | 1,000 | -936 | 577 |
| Financing Cash Flow | $7,915 | $32,129 | $171,091 | $35,595 | $12,025 |
| Beginning Cash Position | 59,030 | 40,823 | 20,741 | 9,224 | 29,903 |
| End Cash Position | 92,310 | 59,030 | 40,823 | 20,741 | 9,224 |
| Net Cash Flow | $33,280 | $18,207 | $20,082 | $11,517 | $-20,679 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,754 | 313 | -26,890 | -19,906 | -45,215 |
| Capital Expenditure | -3,604 | -2,783 | -3,161 | -1,974 | -1,085 |
| Free Cash Flow | 2,150 | -2,470 | -30,051 | -21,880 | -46,300 |